Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 2
2005 2
2006 1
2007 1
2008 1
2009 4
2010 3
2011 2
2012 5
2013 4
2014 8
2015 4
2016 7
2017 6
2018 8
2019 4
2020 1
2021 2
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
A Phase I/II Trial of Definitive Carbon Ion Radiotherapy for Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma.
Isozaki T, Ishikawa H, Yasuda S, Isozaki Y, Yamada S, Akutsu Y, Nagata M, Nabeya Y, Minashi K, Murakami K, Kuwano H, Nemoto K, Tsuji H, Uno T, Matsubara H. Isozaki T, et al. Among authors: yasuda s. Int J Radiat Oncol Biol Phys. 2023 Oct 1;117(2):416-421. doi: 10.1016/j.ijrobp.2023.04.014. Epub 2023 Apr 26. Int J Radiat Oncol Biol Phys. 2023. PMID: 37116590 Clinical Trial. No abstract available.
[S-methyl-11C]-L-methionine positron emission tomography/computed tomography imaging parameters to evaluate early response for esophageal cancer with neoadjuvant carbon ion radiotherapy.
Narushima K, Nishii R, Okazumi S, Shimada H, Akutsu Y, Maeda T, Yasuda S, Yamada S, Shuto K, Tamura K, Yamazaki K, Shinoto M, Ishikawa H, Mori M, Matsubara H. Narushima K, et al. Among authors: yasuda s. Sci Rep. 2022 Aug 11;12(1):13694. doi: 10.1038/s41598-022-17962-x. Sci Rep. 2022. PMID: 35953702 Free PMC article.
Erratum: Recurrent cholangiocarcinoma with long-term survival by multimodal treatment: A case report.
Sota Y, Einama T, Kobayashi K, Fujinuma I, Tsunenari T, Takihata Y, Iwasaki T, Miyata Y, Okamoto K, Kajiwara Y, Shinto E, Tsujimoto H, Yasuda S, Isozaki Y, Yamada S, Yamamoto J, Ueno H, Kishi Y. Sota Y, et al. Among authors: yasuda s. Mol Clin Oncol. 2021 Jun;14(6):126. doi: 10.3892/mco.2021.2288. Epub 2021 Apr 26. Mol Clin Oncol. 2021. PMID: 33981430 Free PMC article.
Recurrent cholangiocarcinoma with long-term survival by multimodal treatment: A case report.
Sota Y, Einama T, Kobayashibayashi K, Fujinuma I, Tsunenari T, Takihata Y, Iwasaki T, Miyata Y, Okamoto K, Kajiwara Y, Shinto E, Tsujimoto H, Yasuda S, Isozaki Y, Yamada S, Yamamoto J, Ueno H, Kishi Y. Sota Y, et al. Among authors: yasuda s. Mol Clin Oncol. 2021 Apr;14(4):72. doi: 10.3892/mco.2021.2234. Epub 2021 Feb 16. Mol Clin Oncol. 2021. PMID: 33732458 Free PMC article.
Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma.
Kasuya G, Tsuji H, Nomiya T, Makishima H, Haruyama Y, Kobashi G, Hayashi K, Ebner DK, Omatsu T, Kishimoto R, Yasuda S, Igarashi T, Oya M, Akakura K, Suzuki H, Ichikawa T, Shimazaki J, Kamada T; Working Group for Genitourinary Tumors. Kasuya G, et al. Among authors: yasuda s. Oncotarget. 2019 Jan 1;10(1):76-81. doi: 10.18632/oncotarget.26539. eCollection 2019 Jan 1. Oncotarget. 2019. PMID: 30713604 Free PMC article.
69 results